Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
‘Goldilocks’ binding strength determines anti-cancer T-cell efficacy and fate
Immunotherapy, treatments that reinvigorate immune cells’ anti-cancer activity or reprogram T cells to target cancer,…
Possible association between tattoos and lymphoma revealed
A new study (EClinicalMedicine) from Lund University in Sweden suggests that tattoos could be a…
Twenty-hour ‘face-off’ surgery saves cancer patient’s life
A marathon 20-hour operation that involved peeling the skin off a man’s face to remove…
How a tiny worm is helping to find a cure for an extremely rare form of cancer
Anil Mehta, University of Dundee and Gordon Stewart, UCL When the Williamson family from Dundee lost their mother Sue to…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.